Related Experiment Video
Updated: May 15, 2026
Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis
Masato Komatsu1, Tetsuro Yoshimaru, Taisuke Matsuo
1Division of Genome Medicine, Institute for Genome Research, The University of Tokushima, Tokushima, Japan.
Abstract:
Triple negative breast cancer (TNBC) has a poor outcome due to the lack of beneficial therapeutic targets. To clarify the molecular mechanisms involved in the carcinogenesis of TNBC and to identify target molecules for novel anticancer drugs, we analyzed the gene expression profiles of 30 TNBCs as well as 13 normal epithelial ductal cells that were purified by laser-microbeam microdissection. We identified 301 and 321 transcripts that were significantly upregulated and downregulated in TNBC, respectively. In particular, gene expression profile analyses of normal human vital organs allowed us to identify 104 cancer-specific genes, including those involved in breast carcinogenesis such as NEK2, PBK and MELK. Moreover, gene annotation enrichment analysis revealed prominent gene subsets involved in the cell cycle, especially mitosis. Therefore, we focused on cell cycle regulators, asp (abnormal spindle) homolog, microcephaly-associated (Drosophila) (ASPM) and centromere protein K (CENPK) as novel therapeutic targets for TNBC. Small-interfering RNA-mediated knockdown of their expression significantly attenuated TNBC cell viability due to G1 and G2/M cell cycle arrest. Our data will provide a better understanding of the carcinogenesis of TNBC and could contribute to the development of molecular targets as a treatment for TNBC patients.
Insights
Researchers identified novel therapeutic targets for triple-negative breast cancer (TNBC) by analyzing gene expression. Targeting cell cycle regulators like ASPM and CENPK significantly reduced TNBC cell viability, offering new treatment avenues.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Triple-negative breast cancer (TNBC) presents a significant clinical challenge due to limited targeted therapies and poor patient outcomes.
- Understanding the molecular underpinnings of TNBC carcinogenesis is crucial for developing effective anticancer strategies.
Purpose of the Study:
- To elucidate the molecular mechanisms driving TNBC development.
- To identify novel molecular targets for the development of new TNBC therapeutics.
Main Methods:
- Gene expression profiling was performed on 30 TNBC samples and 13 normal breast ductal epithelial cells.
- Laser-microbeam microdissection was used for precise cell purification.
- Bioinformatic analyses, including gene annotation enrichment, identified key cancer-specific genes and pathways.
Main Results:
- 301 transcripts were significantly upregulated, and 321 were downregulated in TNBC.
- 104 cancer-specific genes, including NEK2, PBK, and MELK, were identified.
- Cell cycle regulation, particularly mitosis, emerged as a prominent pathway.
- Knockdown of ASPM and CENPK induced G1 and G2/M cell cycle arrest, reducing TNBC cell viability.
Conclusions:
- The study identifies ASPM and CENPK as promising therapeutic targets for TNBC.
- These findings enhance the understanding of TNBC carcinogenesis.
- The identified targets hold potential for novel drug development in TNBC treatment.
